Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2012
12/06/2012US20120309725 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
12/06/2012US20120309722 Therapeutic regimens for the treatment of immunoinflammatory disorders
12/06/2012US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
12/06/2012US20120309700 Development and evaluation of novel chinese materia medica preparations
12/06/2012US20120308671 Nasal ointment based on white petroleum jelly
12/06/2012US20120308647 Use of mir-30e to treat vascular lesions
12/06/2012US20120308646 Tetracyclic anthraquinones possessing anti-cancer properties
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308610 Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
12/06/2012US20120308609 6-amino-2--9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/06/2012US20120308607 Production and use of human cd124- and cd-116-positive tumor cell lines in the production of allogenic or semi-allogenic immunotherapy agents
12/06/2012US20120308605 Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity
12/06/2012US20120308602 Recombinant RSV Virus Expression Systems And Vaccines
12/06/2012US20120308601 Methods and materials for treating cancer
12/06/2012US20120308598 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins
12/06/2012US20120308596 Novel streptococcus antigens
12/06/2012US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308586 Composition based on extra virgin olive oils
12/06/2012US20120308577 Dna vaccines and methods for the prevention of transplantation rejection
12/06/2012US20120308559 Method of treating hemolytic disease
12/06/2012US20120308557 Immunoglobulin Preparation
12/06/2012US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
12/06/2012US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
12/06/2012US20120308513 Promiscuous her-2/neu cd4 t cell epitopes
12/06/2012US20120308480 Humanized antibodies against tl1a
12/06/2012US20120308479 Brain Endothelial Cell Expression Patterns
12/06/2012DE112010004862T5 Polymorphe Form von Nevirapin und deren Herstellung Polymorphic form of nevirapine and their preparation
12/06/2012CA2838158A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
12/06/2012CA2837895A1 Methods of treating or preventing neurological diseases
12/06/2012CA2837527A1 Fc receptor binding proteins
12/06/2012CA2837046A1 Novel use of rice, rice bran or rice hull extract as a histamine receptor antagonist
12/05/2012EP2530146A1 Immunomodulation using placental stem cells
12/05/2012EP2530145A1 Immunomodulation using placental stem cells
12/05/2012EP2529736A1 Expression promoter for redox-related factor
12/05/2012EP2528946A1 Methods of treating autoimmune diseases with dll4 antagonists
12/05/2012EP2528917A1 Pyrazolopyridine kinase inhibitors
12/05/2012EP2528916A1 Pyrazolopyridine kinase inhibitors
12/05/2012EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/05/2012EP2528901A1 Pyrazole compounds as crth2 antagonists
12/05/2012EP2528894A1 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
12/05/2012EP2528624A1 Extracellular ifi16 as therapeutic agents
12/05/2012EP2528607A2 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections
12/05/2012EP2528606A1 Quinazoline-based t cell proliferation inhibitors
12/05/2012CN1437479B Recombinant intracellular pathogen vaccines and methods for use
12/05/2012CN102812049A 抗过敏剂 Antiallergic agent
12/05/2012CN102812048A Allergy inhibitor
12/05/2012CN102812029A Pyrrolopyrazine derivatives and their use as JAK and SYK inhibitors
12/05/2012CN102812027A Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/05/2012CN102812022A Thiazole and oxazole kinase inhibitors
12/05/2012CN102812013A Novel Kinase Modulators
12/05/2012CN102811739A T Cell Activation Inhibitor, Pharmaceutical Composition Containing Same, And Screening Method For T Cell Activation Inhibiting Substance
12/05/2012CN102811730A Methods for the use of progestogen as a glucocorticoid sensitizer
12/05/2012CN102811725A Dry Whole Milk Preparations Containing Probiotic Micro-organisms
12/05/2012CN102807987A Meretrix intracellular copper zinc superoxide dismutase gene and application thereof
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807568A Thiadiazole derivative DPP-IV (dipeptidyl peptidase IV) inhibitor
12/05/2012CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805859A Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
12/05/2012CN102805774A Chinese medicinal superfine powder for improving organism immunity of livestock and poultry and preparation method thereof
12/05/2012CN102805762A Chinese magnoliavine fruit polysaccharide extract and preparation method and application thereof
12/05/2012CN102327227B Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid
12/05/2012CN102321514B Health-care wine
12/05/2012CN102258758B High-content liquid gingerols and preparation method thereof
12/05/2012CN102258552B Method for preparing angelica dahurica decoction pieces
12/05/2012CN102258535B Method for preparing veterinary compound iron dextran injection and influence of veterinary compound iron dextran injection on growth of mice
12/05/2012CN101934044B Novel application of ginseng, tuckahoe and atractylodes preparation
12/05/2012CN101756988B Compound matrine and diversine nano-emulsion preparation and preparation method thereof
12/05/2012CN101565404B Heterocyclic compounds
12/05/2012CN101151041B Composition for immune activation
12/05/2012CN101068536B Dosage regimen of an S1P receptor agonist
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324283 Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2524939C Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
12/04/2012CA2518932C 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2340304C Multicomponent vaccines
12/04/2012CA2261630C Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
11/2012
11/29/2012WO2012162637A2 Vaccine adjuvants from self-assembling peptides
11/29/2012WO2012162564A1 Method for inducing an immune response and formulations thereof
11/29/2012WO2012162392A1 Endothelium protective materials and methods of use
11/29/2012WO2012162254A1 Inhibitors of lrrk2 kinase activity
11/29/2012WO2012160464A1 Heterocyclic compounds as protein kinase inhibitors
11/29/2012WO2012160447A1 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
11/29/2012WO2012160215A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
11/29/2012WO2012160187A1 Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
11/29/2012WO2012160186A1 Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
11/29/2012WO2012160184A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160183A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160030A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/29/2012WO2012139089A3 Fungal-derived carbohydrate-conjugated scaffold
11/29/2012WO2012136224A3 Granulocyte -macrophage colony stimulating factor for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 1172